Literature DB >> 6892914

Enzymatic synthesis of folylpolyglutamates. Characterization of the reaction and its products.

J J McGuire, P Hsieh, J K Coward, J R Bertino.   

Abstract

Rat liver folylpolyglutamate synthetase was partially purified and its reaction and products were characterized. The preparation contained no conjugase activity. Gel filtration analysis revealed a molecular weight of 69,000. The synthetase was optimally active at pH 8.4 (37 degrees C), required mercaptoethanol and a monovalent cation, and was highly specific for L-glutamate. Only purine nucleoside triphosphates served as the energy source for the reaction; ATP and dATP gave the best activity. All naturally occurring folates (including 5-methyl-tetrahydrofolic acid) as well as a number of folate analogs (including methotrexate) served as substrates. The unnatural diastereoisomer of at least one folate, 5,6,7,8-tetrahydrofolic acid, was also a substrate. Modifications of the terminal, acceptor glutamate led to loss of substrate activity, as well as loss of binding. High pressure liquid chromatography analysis, conjugase digestion, double radiolabel studies, and amino acid analysis of acid-hydrolyzed product confirmed that folylpoly-gamma-glutamates were synthesized. High concentrations of (dl)-5,6,7,8-tetrahydrofolic acid favored accumulation of short chain (predominantly diglutamate) products while low concentrations favored accumulation of longer chains (predominantly tetraglutamate). This inverse relationship between concentration and chain length may be of regulatory significance. Synthesis of pentaglutamate forms, the predominant chain length of rat liver folates in vivo, was detected at low (dl)-5,6,7,8-tetrahydrofolic acid, but hexaglutamate was not detected. Synthetic (l)-5,6,7,8-tetrahydropteroylpentaglutamate was a poor substrate for the synthetase but it inhibited formation of polyglutamates from monoglutamates. These observations indicate that the predominant chain length of folates in rat liver may be determined solely by the substrate specificity of the rat liver synthetase. Inhibition by the specificity of the rat liver synthetase. Inhibition by the pentaglutamate derivative offers a means by which folylpolyglutamates could regulate their own synthesis.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6892914

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  33 in total

1.  Inhibition of thymidylate synthase by the diastereoisomers of leucovorin.

Authors:  P P Lee; R L Schilsky
Journal:  Cancer Chemother Pharmacol       Date:  1990       Impact factor: 3.333

Review 2.  Polyglutamation of methotrexate. Is methotrexate a prodrug?

Authors:  B A Chabner; C J Allegra; G A Curt; N J Clendeninn; J Baram; S Koizumi; J C Drake; J Jolivet
Journal:  J Clin Invest       Date:  1985-09       Impact factor: 14.808

3.  Potent dual thymidylate synthase and dihydrofolate reductase inhibitors: classical and nonclassical 2-amino-4-oxo-5-arylthio-substituted-6-methylthieno[2,3-d]pyrimidine antifolates.

Authors:  Aleem Gangjee; Yibin Qiu; Wei Li; Roy L Kisliuk
Journal:  J Med Chem       Date:  2008-09-25       Impact factor: 7.446

4.  Inhibition of human folylpolyglutamate synthetase by diastereomeric phosphinic acid mimics of the tetrahedral intermediate.

Authors:  John J McGuire; David M Bartley; John W Tomsho; William H Haile; James K Coward
Journal:  Arch Biochem Biophys       Date:  2009-06-27       Impact factor: 4.013

5.  Novel pyrrolo[2,3-d]pyrimidine antifolate TNP-351: cytotoxic effect on methotrexate-resistant CCRF-CEM cells and inhibition of transformylases of de novo purine biosynthesis.

Authors:  F Itoh; O Russello; H Akimoto; G P Beardsley
Journal:  Cancer Chemother Pharmacol       Date:  1994       Impact factor: 3.333

6.  Concentration-dependent processivity of multiple glutamate ligations catalyzed by folylpoly-gamma-glutamate synthetase.

Authors:  John W Tomsho; Richard G Moran; James K Coward
Journal:  Biochemistry       Date:  2008-08-02       Impact factor: 3.162

7.  Characterisation of the bifunctional dihydrofolate synthase-folylpolyglutamate synthase from Plasmodium falciparum; a potential novel target for antimalarial antifolate inhibition.

Authors:  Ping Wang; Qi Wang; Yonghong Yang; James K Coward; Alexis Nzila; Paul F G Sims; John E Hyde
Journal:  Mol Biochem Parasitol       Date:  2010-03-27       Impact factor: 1.759

Review 8.  Pharmacokinetics of anticancer drugs in children.

Authors:  W R Crom; A M Glynn-Barnhart; J H Rodman; M E Teresi; R E Kavanagh; M L Christensen; M V Relling; W E Evans
Journal:  Clin Pharmacokinet       Date:  1987-03       Impact factor: 6.447

9.  Chronic cobalamin inactivation impairs folate polyglutamate synthesis in the rat.

Authors:  J Perry; I Chanarin; R Deacon; M Lumb
Journal:  J Clin Invest       Date:  1983-05       Impact factor: 14.808

10.  Expression cloning of a human cDNA encoding folylpoly(gamma-glutamate) synthetase and determination of its primary structure.

Authors:  T A Garrow; A Admon; B Shane
Journal:  Proc Natl Acad Sci U S A       Date:  1992-10-01       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.